NPPA has intimated that IPDMS portal and Pharma Jan Samadhan portal is temporarily suspended
Any complaints regarding overpricing, shortage, sale without prior approval, refusal of supply or non-availability of drugs shall be mailed to National Pharmaceutical Pricing Authority.
NMC introduces measures to ensure the mental health and social well being of post graduate medical students
An actions taken report on issues like suicides, gender bias, incidence of dishonor to decency of women etc. and practices being followed in the institution the check these issues shall be provided to National Medical Commission on a regular basis by all institutions of medical education.
Drugs (Sixth Amendment) Rules, 2022
The amendment has provided that in case of disinfectants, the colors referred in IS 4707 (Part I) as amended by Bureau of Indian Standards from time to time shall be permissible to use.
Classification of medical device pertaining to Rehabilitation under the provisions of Medical Devices Rules, 2017
The devices are classified into Class A and Class B based on factors such as intended use, risks associated with the device, etc.
The Assisted Reproductive Technology (Regulation) and Surrogacy (Regulation) (Removal of Difficulties) Order, 2022.
As per the order the Assisted Reproductive Technology clinics, Assisted Reproductive Technology banks and Surrogacy clinics, falling under the jurisdiction of the 17 States as notified, are allowed to conduct counselling or procedures pertaining to Assisted Reproductive Technology and Surrogacy beyond 24.07.2022 and up to a maximum period of 3 months ( i.e. up to 24.10.2022).
NMC directs registration of all Medical Colleges in All India Survey on Higher Education
Inclusion of all institutions in the AISHE is necessary as the next round of applications for scholarships will start shortly.
Capped trade margin for medical devices
Trade margin of five medical devices, namely, (i) Pulse Oximeter, (ii) Blood Pressure Monitoring Machine, (iii) Nebulizer, (iv) Digital Thermometer, and (v) Glucometer at capped at 70%.
Department of Pharmaceuticals invites application for Vitamin B1 under the category ‘Other Chemical Synthesis based KSMs/Drug Intermediates/APIs’ under Production Linked Incentive (PLI) scheme for Bulk Drugs.
Under this Scheme, the Eligible Product ‘Vitamin B1’ was categorised under the head‘Fermentation based niche KSMs/ Drug Intermediaries/ APIs’ and applications were invited accordingly. However, representations were received subsequently that the Vitamin B1 can be manufactured through chemical synthesis route also. Therefore, the classification of the Eligible Product: ‘Vitamin B1’ has been changed to ‘Other Chemical Synthesis based KSMs/ Drug Intermediaries/ APIs’.
NMC relaxes the requirement for completion of Basic Course in Medical Education Technology for faculty appointment in medical colleges
The faculty availing this relaxation shall complete the Basic Course in Medical Education Technology course within three years of promotion.
Schemes for Strengthening Pharmaceuticals Industry with Focus on MSMEs and Clusters
In order to strengthen the supply chain of Pharmaceuticals industry where MSMEs are an integral part, Govt of India shall be incentivizing the intending MSME units going in for acquiring Schedule M certification or WHO GMP Certification through the sub-scheme Pharmaceuticals Industry Technology Upgradation Assistance Scheme (PTUAS)
